Drug intelligence / Profile preview

HOMO 16

Development stage
Unknown
Lead developer
Sinsan Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

HOMO 16 is a multi-ingredient therapeutic formulation developed by Sinsan Pharmaceuticals, primarily indicated for the management of metabolic and cardiovascular health in patients with diabetes. The core formulation is a combination of B-vitamins (Pyridoxine, Cyanocobalamin, and Folic Acid) and essential minerals (Zinc, Selenium, and Chromium). Its primary mechanism of action involves the reduction of homocysteine levels—a significant risk factor for cardiovascular disease—by providing the necessary cofactors for the methionine and cystathionine metabolic pathways. Additionally, Chromium picolinate is included to enhance insulin sensitivity and glucose metabolism, while Zinc and Selenium provide antioxidant support to mitigate oxidative stress associated with chronic metabolic conditions. The product is available in specialized variants: HOMO 16 D, which incorporates Vitamin D3 for bone and immune health, and HOMO 16 LC, which contains L-carnitine to support cellular energy production and fatty acid metabolism. It is approved and marketed for indications such as diabetic neuropathy and cardiovascular risk reduction.

Brand names
HOMO 16HOMO16HOMO-16HOMO 16 DHOMO16 DHOMO-16 DHOMO 16 LCHOMO16 LCHOMO-16 LC
Other names
HOMO-16HOMO16HOMO 16
02

Targets

MTR (Methionine synthase)CBS (Cystathionine beta-synthase)INSR (Insulin receptor)MTHFR (Methylenetetrahydrofolate reductase)

Beyond the preview

Go deeper on HOMO 16.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HOMO 16.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call